VeriChip Corporation ("VeriChip") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and Independent Dialysis Foundation (IDF), Maryland's largest independent dialysis center operator, announced today a partnership to provide the VeriMed? Patient Identification System, which consists of the first and only FDA-cleared, implantable RFID microchip that links to patients' medical history, to dialysis patients. The purpose of the partnership is to examine the use of the VeriMed implantable microchip in this patient population.

?VeriChip is deeply committed to supporting the dialysis community and helping to drive improved patient care,? stated Scott R. Silverman, Chairman and Chief Executive Officer of VeriChip Corporation. ?Through our partnership with Independent Dialysis Foundation, dialysis patients can receive the VeriMed implantable microchip and the peace of mind that comes with knowing that their medical history will be available in an emergency ? regardless of their ability to communicate. We believe patients receiving dialysis, who tend to present with various co-morbidities and medications, and are more frequently admitted to emergency departments, are an important audience to benefit from the VeriMed Patient Identification System.?

?IDF has always embraced the latest technology as a means to provide our patients the best possible care,? said Dr. John Sadler, Chief Executive Officer and Founder of Independent Dialysis Foundation. ?Improving access to dialysis patients' medical information by healthcare providers at critical times, such as in emergency rooms, through devices such as VeriMed, has the potential to make a significant impact.?

The partnership will provide IDF's 500 patients and their families access to the VeriMed implantable microchip. At the end of one year, VeriMed will be assessed by patient acceptance rates, rate of complications, patient interviews, and utility of the VeriMed information accessed at various points of care.

About Independent Dialysis Foundation

Independent Dialysis Foundation (IDF) is a not-for-profit company affiliated with the University of Maryland seeking to promote independence, self-care, and stability for dialysis patients. IDF operates 6 freestanding dialysis centers, 1 facility in a nursing home, 2 certified hospital facilities, and inpatient service in 5 hospitals.

About VeriChip

VeriChip, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.

VeriChip is majority-owned by Applied Digital Solutions, Inc. (Nasdaq:ADSX), which also owns a majority position in Digital Angel Corporation (Amex:DOC). For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.

Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.

VeriChip, Delray Beach
Allison Tomek, 561-805-8008